ARCH Venture Partners X, LLC - Insider Trading & Ownership

Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Partners X, LLC is at least $133M dollars as of October 29, 2025. ARCH Venture Partners X, LLC is the 10%+ Owner of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $66.4M. ARCH Venture Partners X, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $25.1M. ARCH Venture Partners X, LLC is the 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $23.5M. ARCH Venture Partners X, LLC is the 10%+ Owner of Erasca, Inc. and owns shares of Erasca, Inc. (ERAS) stock worth about $17.6M.
Signature
ARCH Venture Fund X, L.P. By: ARCH Venture Partners X, L.P., its General Partner By: ARCH Venture Partners X, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of ARCH Venture Partners X, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. 10%+ Owner $66.4M +$5M +8.15% Oct 27, 2025
VERV Verve Therapeutics, Inc. 10%+ Owner $25.1M Jun 21, 2021
PRME Prime Medicine, Inc. 10%+ Owner $23.5M Aug 1, 2025
ERAS Erasca, Inc. 10%+ Owner $17.6M Jul 20, 2021
MAZE Maze Therapeutics, Inc. 10%+ Owner Jan 30, 2025

Insider Transactions Reported by ARCH Venture Partners X, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.